NCT06932211

Brief Summary

This study is a double-blind, randomised, parallel group efficacy study. A minimum of 240 healthy female and male participants aged 18-70 years will be enrolled onto the study according to the inclusion/exclusion criteria. The accepted participants will then be randomly allocated to one of the two test products which they will use at home, twice a day for the duration of the study. Dental assessments of gingival condition and plaque level will be conducted after 4, 13 and 26 weeks of product use at the study site.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
251

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 29, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

April 9, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

6 months

First QC Date

April 9, 2025

Last Update Submit

April 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in gingival condition as measured by Gingival Index

    The gingival condition was assessed using gingival index (GI) \[1\]. The scoring criteria were: 0 = Absence of inflammation; 1 = Mild inflammation - slight change in colour and little change in texture; 2 = Moderate inflammation - moderate glazing, redness, oedema, and hypertrophy (bleeding on pressure); 3 = Severe inflammation - marked redness and hypertrophy (tendency to spontaneous bleeding). Each eligible tooth was scored at six sites: facial (body, mesial, distal) and lingual (body, mesial, distal). The participant's score at each timepoint is the average of all tooth sites measured. \[1\] LOE H, SILNESS J. Acta Odontol Scand. 1963;21:533-551.

    13 weeks

Secondary Outcomes (2)

  • Change in gingival condition as measured by Gingival Index

    4 weeks and 26 weeks

  • Change in plaque levels as measured by Modified Quigley and Hein Plaque Index

    4 weeks, 13 weeks and 26 weeks

Study Arms (2)

Test toothpaste

EXPERIMENTAL

Toothpaste containing proteins, enzymes and 1450 ppm fluoride as sodium fluoride

Other: Toothpaste containing proteins and enzymes

Negative control toothpaste

ACTIVE COMPARATOR

Toothpaste containing 1450 ppm fluoride as sodium fluoride

Other: Control fluoride toothpaste

Interventions

Toothpaste containing proteins, enzymes and 1450 ppm fluoride as sodium fluoride

Test toothpaste

Toothpaste containing sodium fluoride at 1450 ppm F

Negative control toothpaste

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be in good general health.
  • Be willing and physically able to carry out all study procedures.
  • Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form.
  • Have at least 20 natural teeth without subgingival calculus including 5 teeth (excluding 3rd molars) in each quadrant, which can be assessed.
  • Have mean Gingival Index (GI) score between 1.0 and 2.0 (1.0 ≤ Mean GI ≤ 2.0) and mean Plaque Index (PI) ≥ 1.5 at screening and baseline.
  • Not have had a scale and prophylaxis in the month prior to enrolment or have one scheduled prior to the end of the study.
  • Be willing to use only the test products for 6 months, after brushing with the products on site.
  • Brush teeth twice daily (once in the morning and once at night).

You may not qualify if:

  • Pregnant or breast feeding mothers.
  • Subjects who participated in gum health study within 3 months prior to screening.
  • Current participation in any other cosmetic trials, any dental clinical trials or clinical trials.
  • Subjects who have used gum health products in the 4 weeks prior to screening.
  • Obvious signs of untreated caries or significant periodontal disease, which in the opinion of the study dentist, will affect either the scientific validity of the study or if the participant was to participate in the study would affect their wellbeing.
  • Full or partial dentures wearers.
  • Current orthodontic treatment.
  • Smokers or those who have a recent smoking history, including e-cigarettes.
  • Diabetics.
  • Medical condition and/or regular use of any medication which might affect the outcome of the study, as determined by the study dentist, principally a course of anti-inflammatory, antimicrobial or statin drugs within 4 weeks of screening.
  • Taking dietary supplements (e.g. multivitamins, antioxidants, fish oils, etc.).
  • Vegetarians and Vegans.
  • Allergic to any ingredient of study products.
  • The subject is a Unilever employee or a member of the study team.
  • Any participant who, in the judgement of the investigator, should not participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Stomatology, Xi'an Jiaotong University

Xi'an, Shaanxi, 710004, China

Location

Related Publications (1)

  • Hu X, Zhang P, Zhang L, Matheson JR, Lin S, Sun JN, Delfanti C, Tian J, Gupta AK, Vasantharaghavan R, Huang R. The effect of enzyme and protein containing toothpaste on gingival condition: a randomised controlled study. BMC Oral Health. 2025 Nov 3;25(1):1727. doi: 10.1186/s12903-025-07096-7.

MeSH Terms

Conditions

GingivitisDental Plaque

Interventions

Enzymes

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesDental DepositsTooth Diseases

Intervention Hierarchy (Ancestors)

Enzymes and Coenzymes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Statistician
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2025

First Posted

April 17, 2025

Study Start

October 29, 2018

Primary Completion

April 30, 2019

Study Completion

April 30, 2019

Last Updated

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Consent was not obtained from participants for this purpose.

Locations